KBGGY vs. NVO
KBGGY (Kongsberg Gruppen ASA) and NVO (Novo Nordisk A/S) are both stocks. KBGGY operates in Aerospace & Defense (Industrials), while NVO operates in Biotechnology (Healthcare). Over the past 3 years, KBGGY returned 71.26%/yr vs -16.12%/yr for NVO. At a 0.13 correlation, their price movements are largely independent.
Performance
KBGGY vs. NVO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KBGGY achieves a 59.52% return, which is significantly higher than NVO's -12.70% return.
KBGGY
- 1D
- -2.65%
- 1M
- 6.87%
- YTD
- 59.52%
- 6M
- 72.82%
- 1Y
- 12.16%
- 3Y*
- 71.26%
- 5Y*
- —
- 10Y*
- —
NVO
- 1D
- -2.61%
- 1M
- -2.19%
- YTD
- -12.70%
- 6M
- -6.35%
- 1Y
- -38.32%
- 3Y*
- -16.12%
- 5Y*
- 3.67%
- 10Y*
- 6.45%
KBGGY vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
KBGGY Kongsberg Gruppen ASA | 59.52% | 19.00% | 164.60% | -2.54% |
NVO Novo Nordisk A/S | -12.70% | -39.22% | -15.93% | 21.90% |
Correlation
The correlation between KBGGY and NVO is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since May 22, 2023 | 0.13 |
Fundamentals
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KBGGY vs. NVO — Risk / Return Rank
KBGGY
NVO
KBGGY vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Kongsberg Gruppen ASA (KBGGY) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| KBGGY | NVO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.16 | -0.74 | +0.90 |
Sortino ratioReturn per unit of downside risk | 0.84 | -0.85 | +1.68 |
Omega ratioGain probability vs. loss probability | 1.12 | 0.88 | +0.25 |
Calmar ratioReturn relative to maximum drawdown | 0.22 | -0.68 | +0.89 |
Martin ratioReturn relative to average drawdown | 0.28 | -1.01 | +1.29 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| KBGGY | NVO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.16 | -0.74 | +0.90 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.10 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.20 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.12 | 0.47 | +0.65 |
Drawdowns
KBGGY vs. NVO - Drawdown Comparison
The maximum KBGGY drawdown since its inception was -68.35%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for KBGGY and NVO.
Loading charts...
Drawdown Indicators
| KBGGY | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.35% | -74.70% | +6.35% |
Max Drawdown (1Y)Largest decline over 1 year | -68.35% | -55.03% | -13.32% |
Max Drawdown (3Y)Largest decline over 3 years | -68.35% | -74.70% | +6.35% |
Max Drawdown (5Y)Largest decline over 5 years | — | -74.70% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -74.70% | — |
Current DrawdownCurrent decline from peak | -42.83% | -68.81% | +25.98% |
Average DrawdownAverage peak-to-trough decline | -20.00% | -17.75% | -2.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 53.32% | 36.77% | +16.55% |
Volatility
KBGGY vs. NVO - Volatility Comparison
Kongsberg Gruppen ASA (KBGGY) has a higher volatility of 15.41% compared to Novo Nordisk A/S (NVO) at 7.70%. This indicates that KBGGY's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KBGGY | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.41% | 7.70% | +7.71% |
Volatility (6M)Calculated over the trailing 6-month period | 37.99% | 37.81% | +0.18% |
Volatility (1Y)Calculated over the trailing 1-year period | 77.45% | 51.76% | +25.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 61.73% | 38.20% | +23.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 61.73% | 32.49% | +29.24% |
Dividends
KBGGY vs. NVO - Dividend Comparison
KBGGY's dividend yield for the trailing twelve months is around 23.83%, more than NVO's 4.20% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
KBGGY Kongsberg Gruppen ASA | 23.83% | 5.82% | 1.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 4.20% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
KBGGY vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Kongsberg Gruppen ASA and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
KBGGY and NVO have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KBGGY has higher volatility (15.41%) compared to NVO (7.70%). In terms of maximum drawdown, KBGGY dropped -68.35% vs NVO's -74.70%.
KBGGY currently has the higher Sharpe Ratio (0.16 vs -0.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KBGGY and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer